A3191193−Celecoxib in genotype positive familial adenomatous polyposis

• Research type

  Research Study

• Full title

  A phase III placebo-controlled trial of celecoxib in genotype positive subjects with familial adenomatous polyposis

• IRAS ID

  21305

• Sponsor organisation

  Pfizer Ltd

• Eudract number

  2006-002228-40

• Clinicaltrials.gov Identifier

  NCT00585312

• Research summary

  N/A

• REC name

  London - Central Research Ethics Committee

• REC reference

  09/H0718/36

• Date of REC Opinion

  5 Nov 2009

• REC opinion

  Further Information Favourable Opinion